Document Detail

Fat-soluble vitamins as disease modulators in multiple sclerosis.
MedLine Citation:
PMID:  23190287     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: Fat-soluble vitamins (A, D, E and K) have properties that could be relevant as modulators of disease activity in multiple sclerosis (MS).
METHODS: We performed a systematic search on PubMed and Medline up to May 2012, using the search strings 'vitamin A', 'retinol', 'retinal', 'carotenoids', 'vitamin D', 'vitamin E', 'alpha-tocopherol', 'vitamin K' in conjunction with 'multiple sclerosis', 'animal model' and 'experimental autoimmune encephalitis (EAE)'. In addition, the reference lists of the publications identified were examined for further citations of relevance.
RESULTS: There is comprehensive evidence from epidemiological, observational, and experimental studies that vitamin D may be beneficial in MS. Results from small-scale clinical studies are inconclusive, and large-scale, adequately powered, randomized, controlled trials are still lacking. For vitamin D, Oxford Centre for Evidence-Based Medicine level 2c evidence exists for a positive therapeutic effect. Evidence from animal models indicates that all the examined fat-soluble vitamins could have potential as modulators of disease activity in MS. For vitamin A and E, level 4 and 5 evidence exists for a modulatory effect in MS; for vitamin K, too few studies have been conducted to indicate an effect in humans.
CONCLUSION: Vitamin D is a promising candidate as modulator of disease activity in MS, and controlled studies are currently being conducted. All the fat-soluble vitamins have, however, been demonstrated to be effective in different animal models for the disease, and vitamin A and E have biological properties that could be relevant for MS pathogenesis. Thus, vitamin A and E seem to be promising candidates for future case-control and cohort studies.
O Torkildsen; K I Løken-Amsrud; S Wergeland; K-M Myhr; T Holmøy
Related Documents :
20434267 - Oral treatment of rodents with ivermectin for the control of phlebotomus papatasi (dipt...
7345387 - The development of parafilaria bovicola in musca xanthomelas and musca lusoria.
12192907 - Laboratory evaluation of two novel strategies to control first-instar gypsy moth larvae...
20402357 - Colonization and biology of the frog-feeding mosquito uranotaeinia macfarlanei in the r...
8919697 - High-fat, high-cholesterol diet raises plasma hdl cholesterol: studies on the mechanism...
637427 - High-fiber diets in the treatment of diabetes mellitus.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Acta neurologica Scandinavica. Supplementum     Volume:  -     ISSN:  1600-5449     ISO Abbreviation:  Acta Neurol. Scand., Suppl.c     Publication Date:  2013  
Date Detail:
Created Date:  2012-11-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370337     Medline TA:  Acta Neurol Scand Suppl     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  16-23     Citation Subset:  IM    
Copyright Information:
© 2012 John Wiley & Sons A/S.
Department of Neurology, Norwegian Multiple Sclerosis Competence Centre, Haukeland University Hospital, Bergen, Norway; Department of Clinical Medicine, Kristian Gerhard Jebsen MS Research Centre, University of Bergen, Bergen, Norway.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Reduced immunoglobulin levels in epilepsy patients treated with levetiracetam, lamotrigine, or carba...
Next Document:  Clinical assessment and management of sleep disorders in multiple sclerosis: a literature review.